ORLANDO, Dec. 7, 2025) A chemotherapy-free combination treatment outperformed a combination of targeted therapy and chemotherapy among patients with ...

Eli Lilly and Company (NYSE: LLY) today announced results from the Phase 3 BRUIN CLL-313 clinical trial of Jaypirca ...

Patients in 200 mg BID cohort had median progression free survival of 6.2 months and median overall survival of 28.1 months, comparing favorably to results with other therapies Data supports ongoing ...

Discusses SCOPE Phase II Data: iSCIB1+ Shows Improved Progression-Free Survival in Advanced Melanoma December 11, 2025 9:00 ...

The investigational, oral selective estrogen receptor degrader (SERD) giredestrant given as an adjuvant therapy showed significant ...

Discusses ASH Conference Data Updates and Portfolio Progress Including Anemia and Iron Restriction Programs December 7, 2025 ...

On Dec. 5, the Eugene and Springfield police departments announced they are ending their contracts with Flock Safety, the vendor both departments had engaged for Automated License Plate Reader cameras ...

This study retrospectively analyzed ten pediatric patients with HOX-driven AML who received revumenib maintenance after HSCT at a single-center. The median age was 10 years (range: 1-18). 80% (8/10) ...

In North Idaho, a local mom’s efforts to wrest school board control from MAGA conservatives ended in disappointment on Election Day. How it happened carries a message about political power.

Oral presentation from pooled analyses of the IMerge population suggests that treatment-emergent cytopenias may reflect on-target effects associated with meaningful clinical outcomes, including hemogl ...

Ohio State wide receiver Phillip Bell III was dragged through the world of Southern California high-school football, where a ...

Age be damned: Max Scherzer can still get it done. Last season, the 41-year-old Scherzer was part of the Toronto Blue Jays' starting rotation and a reputable force in the postseason, recording a 3.77 ...